Successful recovery from lung injury requires the repair and regeneration of alveolar epithelial cells to restore the integrity of gas-exchanging regions within the lung and preserve organ function. Improper regeneration of the alveolar epithelium is often associated with severe pulmonary fibrosis, the latter of which involves the recruitment and activation of fibroblasts, as well as matrix accumulation. Type 2 alveolar epithelial cells (AEC2s) are stem cells in the adult lung that contribute to the lung repair process. The mechanisms that regulate AEC2 renewal are incompletely understood. We provide evidence that expression of the innate immune receptor Toll-like receptor 4 (TLR4) and the extracellular matrix glycosaminoglycan hyaluronan (HA) on AEC2s are important for AEC2 renewal, repair of lung injury and limiting the extent of fibrosis. Either deletion of TLR4 or HA synthase 2 in surfactant-protein-C-positive AEC2s leads to impaired renewal capacity, severe fibrosis and mortality. Furthermore, AEC2s from patients with severe pulmonary fibrosis have reduced cell surface HA and impaired renewal capacity, suggesting that HA and TLR4 are key contributors to lung stem cell renewal and that severe pulmonary fibrosis is the result of distal epithelial stem cell failure.
The lung, along with the skin and gut, are the three organs in perpetual contact with the external environment. The gut has evolved mechanisms for mucosal surface protection and repair mostly through its cohabitation with commensal bacterial flora. This symbiotic relationship both protects the gut from insult 1,2 and initiates processes to rapidly invigorate stem cell renewal 3 . In the lung, the alveolar epithelium is vulnerable to noxious injury, and it also encompasses a critical stem-cell-progenitor niche that can overcome such assaults 4, 5 . Timely repair of lung injury is essential for proper restoration of function and determines the outcome of life or death. Inadequate repair can result in abrupt respiratory decompensation, and if protracted, it can lead to potentially fatal outcomes such as fibrosis. During development, type 1 alveolar epithelial cells (AEC1s) and AEC2s arise from a bipotent progenitor cell lineage 6 , whereas after birth, AEC2s can undergo long-term self-renewal and give rise to AEC1s during homeostasis 6, 7 ; however, they can also do so in response to infection 8, 9 or tissue damage 4, 10 .
The mechanisms that both constitutively protect the distal alveolar space and promote the renewal of injured AEC2s are incompletely understood. A critical barrier to progress in ameliorating fibrosis has been the lack of understanding of the interactions between endogenous host factors generated during non-infectious injury and cellular processes that regulate tissue remodeling. We have shown that the innate immune receptors TLR2 and TLR4 and the extracellular matrix glycosaminoglycan HA have important roles in lung injury and repair processes [11] [12] [13] [14] . HA is a glycosaminoglycan polymer comprised of the repeating disaccharide units N-acetyl-glucosamine and D-glucuronic acid 13, 15 , and it is synthesized by membrane-bound synthases 15 . Among the three HA synthases, HA synthase 2 (HAS2) is most critical for development, as its targeted deletion results in an embryonic lethal phenotype owing to failed heart and blood vessel development 16 .
Idiopathic pulmonary fibrosis (IPF) is a lethal disease characterized by abnormal lung epithelial cells and overwhelming matrix accumulation in the lung interstitium. Most patients with IPF deteriorate with a median survival of less than 3 years from diagnosis 17 . Although the exact molecular mechanisms of progressive lung fibrosis are unclear, it is believed that IPF results from numerous micro-injuries to the alveolar epithelia that promote excessive, sustained fibroblast activation into matrix-producing myofibroblasts 18, 19 . Furthermore, surfactant protein deficiency 20 or mutations in the genes encoding surfactant protein C (SFTPC) and surfactant protein A2 (SFTPA2) 21, 22 were noted in familial interstitial lung diseases. A recent study also showed that telomere dysfunction causes alveolar stem cell failure 23 . Collectively, these observations point to alveolar epithelial cells as central in the pathogenesis of IPF, but the renewal capacity of AEC2s from the lungs of individuals with IPF has not been investigated.
Here we propose that HA on the surface of AEC2s functions as a renewal signal. We found that mice with a targeted deletion of Has2 1 2 8 6 VOLUME 22 | NUMBER 11 | NOVEMBER 2016 nature medicine in AEC2s either expressing surfactant protein C (SP-C) or lacking expression of the cognate receptor TLR4 were markedly more susceptible to bleomycin-induced lung injury and developed fulminant interstitial fibrosis. Additionally, AEC2s from these mice had impaired renewal capacity as compared to wild-type (WT) AEC2s. We also found that interleukin (IL)-6 production was diminished in Tlr4-and Has2-deficient mice and that presence of this cytokine promoted three-dimensional (3D) coculture organoid development and reversed the fibrotic phenotype when restored in the early window following lung injury. Furthermore, we observed that AEC2s from patients with IPF were markedly diminished in number, had greatly reduced HA cell surface expression and had impaired renewal capacity, as compared to AEC2s from the lungs of healthy individuals. Collectively, these data suggest that HA and TLR4 promote alveolar stem cell renewal and could lead to novel therapeutic approaches in treating fibrotic lung diseases.
RESULTS

Tlr4
−/− mice are more susceptible to bleomycin injury We previously demonstrated that epithelial cell surface expression of HA, TLR2 and TLR4 is necessary to sustain basal activation of the transcription factor NF-κB and prevent epithelial cell apoptosis 11 .
Here we sought to determine whether TLR-HA interactions could provide lung epithelial cells with signals to promote renewal, in addition to preventing apoptosis. Tlr4 expression was higher in the lungs of WT C57Bl/6 mice after bleomycin-induced injury than in the lungs of uninjured controls (Fig. 1a) . Also, as compared to WT mice, Tlr4 −/− mice were more susceptible to bleomycin-induced lung injury (Fig. 1b) , and they demonstrated a markedly enhanced fibrotic response to even low doses of bleomycin, as illustrated by enhanced trichrome staining ( Fig. 1c) and higher hydroxyproline content in lung tissues 21 d after bleomycin exposure (Fig. 1d) . More severe fibrosis in the mutant mice was also accompanied by higher α-smooth muscle actin (α-SMA; encoded by Acta2) staining (Fig. 1e) and elevated Acta2 expression (Fig. 1f) , as compared to that in WT mice. The morefibrotic phenotype seemed to be specific for a TLR4 deficiency, as the enhanced susceptibility to fibrosis was not observed in Tlr2 −/− mice ( Supplementary Fig. 1a,b) . We investigated the inflammatory response of Tlr4 −/− mice to bleomycin-induced lung injury and found that the number of total bronchoalveolar lavage fluid (BALF) cells, as well as differential inflammatory cell counts, were not different between Tlr4 −/− and WT mice (Supplementary Fig. 2a) . Furthermore, levels of the chemokine CXCL2 (also called MIP-2) in the BALF of Tlr4 −/− mice was lower at day 1 after bleomycin treatment than in WT mice ( Supplementary  Fig. 2b) . Also, there was no difference in transforming growth factor (TGF)-β concentrations in the BALF of Tlr4 −/− and WT mice (Supplementary Fig. 2c ).
Worse alveolar epithelial cell injury in Tlr4 −/− mice Flow cytometry analysis showed that AEC2s abundantly expressed TLR4 (Supplementary Fig. 3a) . Macrophages also expressed TLR4 as expected, and fibroblasts showed minimal TLR4 expression (Supplementary Fig. 3a) . In contrast, TLR2 expression on AEC2s was minimal (Supplementary Fig. 3b ). Cell surface expression of HA on AEC2s from Tlr2 −/− mice was as abundant as that of the WT AEC2s, whereas the cell surface expression of HA was markedly lower on the Tlr4 −/− AEC2s than on the WT AEC2s (Supplementary Fig. 3c ).
We used a mouse lung tissue dissociation and fractionation approach to generate an epithelial cell population (R3; CD45 − CD31 − CD34 − EpCAM + ; Supplementary Fig. 3d ) from which an enriched AEC2 fraction was isolated by selection of the CD24 − Sca1 − subset (R4; hereafter designated CD24 − Sca-1 − AEC2s; Supplementary Fig. 3d ) 24 . We verified that the gated CD24 − Sca-1 − AEC2s were SFTPC + by analyzing lung cells isolated from mice harboring a SFTPC-GFP transgene (Supplementary Fig. 3e,f) or by lineage tracing of AEC2s in SFTPC-CreER;Rosa26-Tomato mice, in which AEC2s express the fluorescent protein Tomato after tamoxifen induction (Supplementary Fig. 3g,h) . In uninjured lungs from SFTPC-GFP transgenic mice, 96.1% of CD24 − Sca-1 − AEC2s were GFP positive (Supplementary Fig. 3e) , and 90.6% of GFP + cells sorted into the CD24 − Sca-1 − gate (Supplementary Fig. 3f) . Similarly, in the lungs of uninjured SFTPC-CreER;Rosa26-Tomato mice 1 week after administration of four tamoxifen injections, 90.8% of CD24 − Sca-1 − AEC2s were Tomato + (Supplementary Fig. 3g) , and 87.5% of lineage-labeled Tomato + cells sorted into the CD24 − Sca-1 − AEC2 gate (Supplementary Fig. 3h ). Immunofluorescence staining showed that 96.67% of FACS-enriched CD24 − Sca-1 − AEC2s were SP-C + (Supplementary Fig. 3i ).
Bleomycin exposure is associated with both a lower percentage of CD24 − Sca-1 − AEC2s within the lung epithelial cell fraction (Fig. 2a) and a lower absolute number of CD24 − Sca-1 − AEC2s recovered from dissociated lung tissue (Fig. 2b) , as compared to those at day 0. The nadir in the lower percentage of CD24 − Sca-1 − AEC2s was observed at day 7 (Fig. 2a) , and the fewest number of CD24 − Sca-1 − AEC2s were recovered from lungs at day 3 after bleomycin treatment (Fig. 2b) . We reasoned that the decline in the percentage of AEC2s and the absolute number were not identical because other cell types in the lung were being differentially affected by the injury. The percentage and number of epithelial cells gradually recovered between day 14 and day 21 after bleomycin treatment (Fig. 2a,b) . Tlr4 expression in CD24 − Sca-1 − AEC2s were lower at day 3 but were then at equivalent levels by day 14 after bleomycin injury, as compared to that in AEC2s from uninjured lungs (Fig. 2c) . The Tlr4 expression pattern correlated with the pattern of CD24 − Sca-1 − AEC2 damage and recovery after bleomycin injury. Furthermore, we observed even lower levels of CD24 − Sca-1 − AEC2s in bleomycin-injured lungs from Tlr4 −/− mice versus WT mice at multiple time points after injury ( Fig. 2b,d ). There was no difference between the numbers of CD24 − Sca-1 − AEC2s recovered from the uninjured lungs of Tlr4 −/− and WT mice (Fig. 2b) . In addition, we observed that a CD24 − Sca-1 + population emerged following bleomycin-induced lung injury (Fig. 2a) . The significance of these cells in lung injury is under investigation.
AEC2 proliferation and renewal require TLR4 signaling
To assess the role of TLR4 on AEC2 proliferation in vivo, we performed 5-bromo-2′-deoxyuridine (BrdU) labeling after bleomycin treatment. Immunofluorescence staining showed fewer SFTPC + BrdU + cells in the lungs of Tlr4 −/− mice as compared to those in WT mice 5 d after bleomycin treatment (Fig. 3a,b) . Similarly, fewer AEC2s in Tlr4 −/− mice stained positive for the cell proliferation marker Ki67 than in WT mice (Fig. 3c,d) .
We next compared the colony-forming efficiency (CFE) of CD24 − Sca-1 − AEC2s that were isolated from Tlr4 −/− and WT mice at day 3 after bleomycin injury. Flow-sorted CD24 − Sca-1 − AEC2s were cocultured with mouse lung fibroblasts (Mlg 2908) embedded in matrigel medium mix for the generation of clonally derived 3D organoids. Immunofluorescence staining showed that the epithelial cells at the periphery of the organoids were SFTPC + and that those within the interior were podoplanin (PDPN; also known as T1α) positive, which are indicative of AEC2 or AEC1 differentiation, respectively (Fig. 3e) . Analysis of the replating efficiency of CD24 − Sca-1 − AEC2s isolated from the lungs of WT mice 3 d after bleomycin treatment revealed sustained regenerative capacity within passage (P) 1 and P2 cells (Fig. 3f) . CD24 − Sca-1 − AEC2s isolated from the lungs of Tlr4 −/− mice 3 d after bleomycin treatment formed markedly fewer ( Fig. 3g ) and smaller colonies ( Fig. 3h) than did CD24 − Sca-1 − AEC2s cells isolated from WT lungs, suggesting that the renewal capacity of Tlr4 −/− AEC2s was impaired. CFEs were similar between AEC2 cells isolated from uninjured Tlr4 −/− and WT lungs (Supplementary Fig. 4a ).
Next we tested the hypothesis that TLR4-promoted AEC2 renewal requires the interaction with HA. Addition of high-molecular-mass HA (referred to as Healon) to the Matrigel medium mix increased the CFE of CD24 − Sca-1 − AEC2s isolated from lungs on day 3 after bleomycin treatment of WT but not Tlr4 −/− mice (Fig. 3i) . Healon increased the CFE of CD24 − Sca-1 − AEC2s from uninjured WT mice, and exposure to the HA-blocking peptide pep-1 (refs. 11,25) was able to inhibit the HA-induced increase in CFEs (Fig. 3j) . We investigated the apoptosis of epithelial cells in the bleomycin-injured lungs and found that Tlr4 −/− mice showed more epithelial cell apoptosis at day 3 after bleomycin treatment than WT mice (Supplementary Fig. 4b ).
HA on AEC2s regulates AEC2 renewal and fibrosis
To further define the role of HA in AEC2 renewal, we crossed mice harboring loxP-flanked (floxed) alleles of Has2 (hereafter referred to Fig. 5a,b) . The HA concentrations in the BALF of uninjured SFTPC-Cre;Has2 flox/flox mice was slightly lower than those in the BALF of their littermates (Supplementary Fig. 5c ). There was no difference in the numbers of CD24 − Sca-1 − AEC2s that were recovered from the uninjured lungs of SFTPC-Cre;Has2 flox/flox mice and their littermates (Supplementary Fig. 5d ). Cell surface HA expression was markedly lower on CD24 − Sca-1 − AEC2s isolated from SFTPC-Cre;Has2 flox/flox mice than on AEC2s isolated from control mice (Fig. 4a) . The HA concentrations in the culture medium of CD24 − Sca-1 − AEC2s that were isolated from SFTPC-Cre;Has2 flox/flox mice were also lower than those in the culture medium of CD24 − Sca-1 − AEC2s isolated from their littermates (Fig. 4b) .
To determine whether lower HA expression affects the renewal capacity of AEC2s, we isolated CD24 − Sca-1 − AEC2s from bleomycin-injured mouse lungs and recovered much fewer cells from the lungs of SFTPC-Cre; Has2 flox/flox mice than from their littermates (Fig. 4c) . Ki67 staining of gated CD24 − Sca-1 − AEC2s from bleomycin-treated SFTPC-Cre;Has2 flox/ flox mice on day 3 after treatment was lower than that of AEC2s from control mice (Fig. 4d) . CD24 − Sca-1 − AEC2s from bleomycin-injured SFTPC-Cre;Has2 flox/flox mice showed markedly lower CFEs relative to those of AEC2s from Has2 flox/flox littermates (Fig. 4e) . EpCAM + Lin − epithelial cells from bleomycin-injured SFTPC-Cre;Has2 flox/flox mice also showed more apoptosis than the cells from littermate controls (Supplementary Fig. 5e ). Unlike AEC2s isolated from Tlr4 −/− mice, AEC2s from bleomycin-injured SFTPC-Cre;Has2 flox/flox mice responded to Healon treatment by giving rise to robust colony formation relative to that with the Healon-free Matrigel medium mix (Fig. 4f) .
We hypothesized that lower cell surface expression of HA on AEC2s would lead to enhanced susceptibility to bleomycin injury. Indeed, SFTPC-Cre;Has2 flox/flox mice showed less survival ( Fig. 4g) and more severe lung fibrosis at day 21 after bleomycin treatment as compared to injured littermate controls, as assessed by hydroxyproline content (Fig. 4h) and trichrome staining (Fig. 4i) .
IL-6 promotes AEC2 renewal
Our previous observation that HA-TLR4 interactions are associated with constitutive NF-κB activation in AEC2 cells 11 led us to search for factors downstream of this signaling pathway that might mediate the protective effects of HA and TLR4 on AEC2s. We evaluated BALF composition at various times after injury and found that IL-6 was lower in the BALF of both Tlr4 −/− and SFTPC-Cre;Has2 flox/flox mice, as compared to that in their corresponding controls (Fig. 5a,b) . Microarray analysis also showed that Il6 (which encodes IL-6) was among a cluster of genes whose expression was downregulated in Tlr4 −/− versus WT CD24 − Sca-1 − AEC2s (Supplementary Fig. 6a) . RT-PCR analysis confirmed that Il6 expression was lower in TLR4-deficient CD24 − Sca-1 − AEC2s than in WT AEC2s 4 d after bleomycin treatment (Supplementary Fig. 6b) .
To test the hypothesis that the impaired production of IL-6 might contribute to the impaired renewal capacity of CD24 − Sca-1 − AEC2s from Tlr4 −/− and SFTPC-Cre;Has2 flox/flox mice, the CFEs of CD24 − Sca-1 − AEC2s in 3D organoid culture following treatment with either recombinant IL-6 protein (rIL-6) or IL-6-specific antibodies were evaluated. Treatment with anti-IL-6 reduced, whereas treatment with rIL-6 increased, the CFEs of CD24 − Sca-1 − AEC2s from bleomycin-treated WT mice in a dose-dependent manner (Fig. 5c,d) . Inhibition of the transcription factor STAT3 abolished the effect of rIL6-promoted colony formation of CD24 − Sca-1 − AEC2s (Supplementary Fig. 6c ), suggesting that IL-6 promotes AEC2 renewal through STAT3. In addition, rIL-6 treatment promoted the CFEs of CD24 − Sca-1 − AEC2s from both bleomycin-treated Tlr4 −/− mice and SFTPC-Cre;Has2 flox/flox mice (Fig. 5e,f) .
To determine whether IL-6 regulates the fibrotic phenotype in vivo, we delivered rIL-6 and anti-IL-6 to bleomycin-treated mice at the early stage of lung injury. rIL-6 treatment of Tlr4 −/− mice resulted in more recovery of CD24 − Sca-1 − AEC2s, greater Ki67 staining of CD24 − Sca-1 − AEC2s and lower concentration of total BALF proteins than in Tlr4 −/− mice that were treated with a control buffer (Fig. 5g) . rIL-6 treatment of Tlr4 −/− mice did not affect AEC2 apoptosis (Supplementary Fig. 6d ) and inflammatory cell infiltration relative to those in buffer-treated Tlr4 −/− mice (Supplementary Fig. 6e ). Bleomycin-injured Tlr4 −/− mice that were treated with rIL-6 showed increased survival as compared to mice that were treated with buffer. In addition, hydroxyproline content was lower in the lungs of Tlr4 −/− mice that were treated with bleomycin and rIL-6, as compared to treatment with bleomycin alone (Fig. 5h) . Similarly, rIL-6 treatment resulted in lower hydroxyproline content in the lungs of SFTPC-Cre; Has2 flox/flox mice that were injured using bleomycin, as compared to those that were treated with buffer (Fig. 5i) . Conversely, bleomycininjured WT mice that were treated with anti-IL-6 showed greater mortality than mice treated with control IgG (Supplementary Fig. 6g ), but we did not observe lower hydroxyproline levels in WT mice treated with anti-IL-6 as compared to the mice that were treated with control IgG (data not shown). Furthermore, delivery of rIL-6 to WT mice did not alter survival or hydroxyproline content, as compared to that for the mice treated with bleomycin alone (data not shown).
AEC2s from patients with IPF have lower cell surface expression of HA To determine whether our observations in the mouse model of Has2-deficient AEC2s have relevance to human disease, we isolated AEC2s from lung explants of human subjects who had undergone lung transplantation because of IPF. By using cell surface markers 29 , we were able to sort AEC2s as CD31 − CD45 − EpCAM + HTII-280 + cells from total single-cell suspensions of lung tissues (R3; Supplementary Fig. 7a ). We observed a dramatically lower percentage of EpCAM + HTII-280 + AEC2s within the gated CD31 − CD45 − (Lin − ) cells in the cell suspension from lung tissue of patients with IPF, relative to those from the lung tissue of healthy donors (Fig. 6a,b) . Cell surface HA expression was markedly diminished on HTII-280 + AEC2s from explant lung tissues of the individuals with IPF, as compared to that from lung tissue of healthy donors, similar to what we had observed in our mouse model (Fig. 6c,d ). We found, using qPCR, lower HAS2 expression in HTII-280 + AEC2s from the patients with IPF relative to that in the cells from healthy donors (Fig. 6e) . These data suggest that our mouse model, which has a targeted deletion of Has2 in distal lung epithelium, recapitulates key aspects of severe pulmonary fibrosis in human disease.
Human HTII-280 + AEC2s expressed TLR4 (Supplementary Fig. 7b ) but minimal TLR2 (Supplementary Fig. 7c ), consistent with a previous report of TLR4 and TLR2 expression on human alveolar epithelial cells 30 . However, there was no difference in TLR4 expression on HTII-280 + AEC2s between subjects with IPF and healthy donors (Supplementary Fig. 7b ). Throughout, data are mean ± s.e.m. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; by one-way ANOVA followed by Sidak's multiple-comparison test (b), two-way ANOVA followed by Holm-Sidak's (f) or Sidak's multiple-comparison test (h), Student's t-test (c-e) or log-rank test (g).
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AEC2s from IPF patients have impaired colony-forming capacity
The observation that HTII-280 + AEC2s from lung tissue of patients with severe pulmonary fibrosis have lower cell surface expression of HA led us to investigate the renewal capacity of these cells. We assessed the renewal capacity of human HTII-280 + AEC2s using 3D matrigel culture (Supplementary Fig. 7d) . Similar to what we had observed in murine AEC2s that were devoid of cell surface HA, HTII-280 + AEC2s from lung tissues of individuals with IPF had lower CFEs (Fig. 6f) and formed smaller colonies (Fig. 6g) relative to AEC2s from the tissue of healthy donors. Furthermore, rIL-6 treatment markedly increased the CFEs of the HTII-280 + AEC2s that were sorted from diseased lung, as compared to growth of these cells in medium without exogenous IL-6 (Fig. 6h) . The concentration (200 µg/ml) of exogenous HA (Healon) that was effective in the murine model increased colony formation of HTII-280 + AEC2s from healthy lungs but not of AEC2s from the patients with IPF (Supplementary Fig. 7e ). Higher concentrations of Healon were required to augment colony formation of HTII-280 + AEC2s from IPF lungs (Supplementary Fig. 7f ).
To further investigate whether loss of cell surface expression of HA on HTII-280 + AEC2 cells in the lungs from the patients with IPF contributed to the impaired renewal capacity of the cells, we flow-sorted HTII-280 + AEC2s that had high HA expression (HA hi ) and low HA expression (HA lo ) from the lungs of both patients with IPF and healthy donors. The majority of HTII-280 + AEC2s from healthy lung were HA hi cells, and in contrast, only a small portion of HTII-280 + AEC2s in the diseased lung were HA hi cells (Fig. 6i) . HA lo HTII-280 + AEC2s had lower CFEs than HA hi HTII-280 + AEC2s from either the diseased or healthy lungs (Fig. 6j) . These data indicate that loss of cell surface expression of HA on AEC2s directly contributes to the impaired renewal capacity. However, the HA hi HTII-280 + AEC2s from diseased lung still showed lower CFEs relative to those in HA hi HTII-280 + AEC2s from healthy lungs (Fig. 6j) , suggesting there may be other factors contributing to impaired AEC2 renewal in subjects with IPF.
Because IPF is histologically characterized as patchy areas of apparent pulmonary parenchymal fibrosis alternating with relatively normal lung architecture, we tested whether AEC2s from severely fibrotic areas behaved differently than those from portions of the lung with less fibrosis in the same lung explant from patients with IPF. Flow cytometry analysis showed that cell suspensions from less fibrotic areas contained relatively higher numbers of HTII-280 + AEC2s than less severely fibrotic areas within the same lung (Supplementary Fig. 8a) . However, the recovery of HTII-280 + AEC2s from the less fibrotic areas was still markedly lower than the recovery from healthy donor lungs ( Fig. 6a and Supplementary Fig. 8a ). The CFEs of HTII-280 + AEC2s showed similar impairment after the AEC2s were isolated from regions that were severely or less severely fibrotic ( Supplementary  Fig. 8b) . Cell surface HA expression on HTII-280 + AEC2s was reduced to the same extent regardless of the degree of tissue fibrosis, although there was some variation (Supplementary Fig. 8c ).
DISCUSSION
One of the critical issues in the pathobiology of lung fibrosis is an insufficient understanding of the molecular mechanisms that regulate AEC2 renewal both during tissue homeostasis and after injury. A major goal of this study was to dissect the role of innate immune receptors and endogenous extracellular matrix molecules in regulating AEC2 renewal and lung fibrosis. The main finding here is that the endogenous matrix glycosaminoglycan HA and the innate immune receptor TLR4 are required for optimal AEC2 renewal and for limiting fibrosis after lung injury. Most notably, we discovered a loss in cell surface expression of HA in AEC2s isolated from the lungs of patients with IPF and that it directly contributes to the impaired renewal capacity of such AEC2s. ; rIL-6, n = 6) (i) mice after treatment with rIL-6 or buffer. Throughout, data are mean ± s.e.m. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; by two-way ANOVA followed by Sidak's multiple-comparison test (a,b,e,f), one-way ANOVA followed by Sidak's multiple-comparison test (c,d) or Student's t-test (g-i).
Previous work from our laboratory demonstrated that HA, as well as TLR4 and TLR2, on epithelial cells were necessary to sustain basal NF-κB activation and prevent epithelial cell apoptosis 11 . In this study, we tested the hypothesis that HA and TLR4 on the cell surface are crucial for AEC2 renewal following injury. We show that AEC2s with deletion of either Tlr4 or Has2 have lower self-renewal capacity in vitro and lead to greater bleomycin-induced lung injury in vivo. Exogenous HA promoted WT AEC2-mediated organoid formation, but this was not observed with AEC2s from Tlr4 −/− mice, suggesting that the interaction between cell-surface-expressed HA and TLR4 is essential for promoting AEC2 renewal. Further study is needed to determine whether there are direct interactions between HA and TLR4.
Epithelial cells from multiple organs-including alveolar epithelial cells 30 , intestinal epithelial cells 31, 32 and keratinocytes 33 -express innate immune receptors such as TLR4. TLRs have a role not only in immunological responses but also in epithelial protection during homeostasis and after injury. The intestinal epithelial TLR4 and commensal bacteria have a key role in protection against bacterial infection 1,2 . We provide evidence here that distal alveolar epithelial TLR4 and HA are crucial in protecting AEC2s from injury and in promoting renewal. These data suggest that cell surface HA may function in a manner similar to commensal bacteria, as the distal alveolar space is devoid of bacteria.
Many downstream signaling events may be altered in the absence of HA-TLR interactions. We present evidence that insufficient production of IL-6 resulted from HA or TLR4 deficiency and that this affected the biology of lung repair both in vitro and in vivo. AEC2s isolated from both injured Tlr4 −/− and SFTPC-Cre;Has2 flox/flox mice demonstrated impaired renewal capacity and that this was significantly reversed by rIL-6 treatment. In addition, exogenous IL-6 treatment during the period of AEC2 vulnerability enhanced AEC2 renewal and partially reversed the fibrotic phenotype in Tlr4 −/− and SFTPC-Cre;Has2 flox/flox mice in vivo. IL-6 is produced by a variety of cell types, including epithelial cells and macrophages 34 . The role of IL-6 in lung injury may be multifold. First, IL-6 may be produced in the reparative niche to promote stem cell renewal [35] [36] [37] . Second, IL-6 is part of a cytokine network that modulates inflammatory responses after bleomycin 38 . Moreover, fibroblasts produce IL-6, and IL-6-STAT3 signaling regulates lung fibrosis 38, 39 . It is conceivable that IL-6 has distinct effects on the biology of fibrosis at varying stages of the disease process. Other factors including CXCL12 and fibroblast growth factor 2 (FGF2) may regulate AEC2 repair after lung injury. We targeted Has2 in SFTPC-positive cells throughout development. This population includes a variety of progenitor-stem cell populations that have recently been identified through lineage tracing 6, 7, 24, 43, 44 or by single-cell transcriptomics analysis 45 . These would not include the recently reported lineage-negative population in the context of severe lung injury 46 . We cannot make conclusions regarding the precise stem cell-progenitor population in the adult mouse lung that is responsible for the observed phenotype of SFTPC-Cre;Has2 flox/flox mice. We believe that the loss of cell surface HA may be more relevant than the specific population. Future studies will be directed at deleting Has2 in adult populations of progenitor cells.
A provocative finding here is that cell surface HA is significantly lower on AEC2s from patients with IPF than in those from healthy individuals. In contrast, we did not identify significant differences in cell surface TLR4 expression between AEC2s from patients with IPF and healthy donors. One of the reasons for the loss of AEC2 surface HA may be a result of the deficiency in HAS2 gene expression. AEC2s with low HA expression from the lungs of either patients with IPF or healthy individuals had dramatically lower organoid-forming ability, suggesting a direct link between the loss of cell surface HA expression (j) CFE between HA hi and HA lo AEC2s from lungs of healthy donors (n = 4 per group) and patients with IPF (n = 3 per group). The results were repeated with cells from two more subjects for each group. Throughout, data are mean ± s.e.m. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; by Student's t-test (b,d-f,h), Mann-Whitney U test (g) or two-way ANOVA followed by Sidak's multiple-comparison test (j).
and the impaired renewal capacity of AEC2s. The finding that exogenous HA was able to augment the colony-forming capacity of AEC2s from fibrotic lungs further supports the concept that the loss of cell surface HA is a cause of impaired renewal of AEC2s from diseased lungs. Higher concentrations of HA were required in human AEC2s, suggesting that there are differences with the mouse model system. These findings support the concept that IPF is primarily a disease of AEC2 stem cell failure. We have identified the loss of the HA-synthesizing enzyme in AEC2s as a primary defect leading to the susceptibility to fibrosis. In addition, we have shown that innate immune receptors can promote epithelial regeneration in addition to the established functions in inflammation. Our mouse model using a targeted deletion of Has2 in distal lung epithelium recapitulates key aspects of severe pulmonary fibrosis in human disease. Notably, AEC2s isolated from lung explants of patients with chronic obstructive pulmonary disease (COPD), another severe lung disease but with a very different pathology, expressed cell surface HA levels similar to that in AEC2s from healthy donors (data not shown), suggesting that loss of cell surface HA on AEC2s is a unique feature of severe pulmonary fibrosis. Future studies will be directed toward ascertaining the mechanisms by which the silencing of HAS2 and subsequent loss of cell surface HA promotes a pro-fibrotic milieu, as well as to identify approaches for restoring cell surface HA on epithelial cells and epithelial cell integrity. These endeavors could lead to new therapeutic approaches in severe pulmonary fibrosis.
METHODS
Methods and any associated references are available in the online version of the paper. 
